BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7864032)

  • 1. Recurrent "retinoic acid syndrome" during induction of remission in acute promyelocytic leukemia.
    Shimoni A; Maor-Kendler Y; Prokocimer M
    Am J Hematol; 1995 Mar; 48(3):207-8. PubMed ID: 7864032
    [No Abstract]   [Full Text] [Related]  

  • 2. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.
    Frankel SR; Eardley A; Heller G; Berman E; Miller WH; Dmitrovsky E; Warrell RP
    Ann Intern Med; 1994 Feb; 120(4):278-86. PubMed ID: 8291820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.
    Breccia M; Latagliata R; Carmosino I; Cannella L; Diverio D; Guarini A; De Propris MS; Petti MC; Avvisati G; Cimino G; Mandelli F; Lo-Coco F
    Haematologica; 2008 Dec; 93(12):1918-20. PubMed ID: 18945746
    [No Abstract]   [Full Text] [Related]  

  • 4. Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia.
    Arun B; Berberian B; Azumi N; Frankel SR; Luksenburg H; Freter C
    Leuk Lymphoma; 1998 Nov; 31(5-6):613-5. PubMed ID: 9922053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute neutrophilic dermatosis induced by all-trans-retinoic acid treatment for acute promyelocytic leukemia.
    Levi I; Raanani P; Shalmon B; Schiby-Brilliant R; Ben-Bassat I
    Leuk Lymphoma; 1999 Jul; 34(3-4):401-4. PubMed ID: 10439378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
    N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute renal failure associated with the retinoic acid syndrome in acute promyelocytic leukemia.
    Flombaum CD; Isaacs M; Reich L; Berman E; Warrell RP
    Am J Kidney Dis; 1996 Jan; 27(1):134-7. PubMed ID: 8546128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-trans retinoic acid and early mortality in acute promyelocytic leukemia.
    Rashidi A; Goudar RK; Sayedian F; Vos JA; Goldin TA; Aguilera NS; Fisher SI
    Leuk Res; 2013 Oct; 37(10):1391-2. PubMed ID: 23906626
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasculitis associated with all trans retinoic acid (ATRA) in a case with acute promyelocytic leukemia.
    Paydas S; Yavuz S; Disel U; Sahin B; Canbolat T; Tuncer I
    Leuk Lymphoma; 2003 Mar; 44(3):547-8. PubMed ID: 12688331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "retinoic acid syndrome" in acute promyelocytic leukemia.
    Frankel SR; Eardley A; Lauwers G; Weiss M; Warrell RP
    Ann Intern Med; 1992 Aug; 117(4):292-6. PubMed ID: 1637024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recently recognized entity associated with the treatment of acute promyelocytic leukemia: the retinoic acid syndrome.
    Marinakis T; Papadimitriou CA; Koufos C; Fertakis A
    Haematologica; 1993; 78(3):192-4. PubMed ID: 8375752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive splenic infarction, deep vein thrombosis and pulmonary emboli complicating induction therapy with all-trans-retinoic acid (ATRA) for acute promyelocytic leukemia.
    Goldschmidt N; Gural A; Ben Yehuda D
    Leuk Lymphoma; 2003 Aug; 44(8):1433-7. PubMed ID: 12952241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of cerebellar thrombohemorrhage during all-trans retinoic acid (ATRA) therapy in a case of acute promyelocytic leukemia.
    Parma M; Casaroli I; Pogliani EM
    Haematologica; 1996; 81(4):379-80. PubMed ID: 8870387
    [No Abstract]   [Full Text] [Related]  

  • 14. [Paralytic ileus during treatment of acute promyelocytic leukemia with all-trans retinoic acid].
    Kanisawa Y; Kawanishi N; Hisai H; Araya H; Akiyama T; Takahari D
    Rinsho Ketsueki; 2000 Aug; 41(8):687-9. PubMed ID: 11020999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].
    Degos L
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):193-5. PubMed ID: 8337123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of acute promyelocytic leukemia with retinoic acid].
    Iavorkovskiĭ LI; Udris OIu; Iavorkovskiĭ LL
    Ter Arkh; 1994; 66(2):87-9. PubMed ID: 8160157
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversible bone marrow necrosis after all-trans retinoic acid induction therapy for acute promyelocytic leukaemia.
    Lakhwani S; Raya JM; González-Brito G; Álvarez-Argüelles H; Brito ML; Hernández-Nieto L
    Pathology; 2011 Aug; 43(5):515-7. PubMed ID: 21753723
    [No Abstract]   [Full Text] [Related]  

  • 18. All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia.
    Citak FE; Ezer U; Akkaya E; Ozbulbul N; Bahce M; Kurekci AE
    Haematologica; 2006 Aug; 91(8 Suppl):ECR35. PubMed ID: 16923519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2. All-trans retinoic acid in the treatment of acute promyelocytic leukemia.
    Asou N
    Intern Med; 2007; 46(2):91-3. PubMed ID: 17220606
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudotumor cerebri in a patient with acute promyelocytic leukemia during treatment with all-trans retinoic acid.
    Sano F; Tsuji K; Kunika N; Takeuchi T; Oyama K; Hasegawa S; Koike M; Takahashi M; Ishida M
    Intern Med; 1998 Jun; 37(6):546-9. PubMed ID: 9678691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.